BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37424733)

  • 1. Genome editing of human embryos for research purposes: Japanese lay and expert attitudes.
    Akatsuka K; Hatta T; Sawai T; Fujita M
    Front Genet; 2023; 14():1205067. PubMed ID: 37424733
    [No Abstract]   [Full Text] [Related]  

  • 2. Human genome editing in clinical applications: Japanese lay and expert attitudes.
    Sawai T; Hatta T; Akatsuka K; Fujita M
    Front Genet; 2023; 14():1205092. PubMed ID: 37662845
    [No Abstract]   [Full Text] [Related]  

  • 3. Public attitudes in Japan toward the creation and use of gametes derived from human-induced pluripotent stem cells.
    Sawai T; Hatta T; Akatsuka K; Fujita M
    Future Sci OA; 2021 Dec; 7(10):FSO755. PubMed ID: 34840812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public attitudes in the clinical application of genome editing on human embryos in Japan: a cross-sectional survey across multiple stakeholders.
    Kobayashi S; Miyoshi T; Kobayashi T; Hayakawa I; Urayama KY; Uchiyama M; Muto K; Takeuchi Y; Taira M; Sago H; Takehara K
    J Hum Genet; 2022 Sep; 67(9):541-546. PubMed ID: 35534678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Need for Better Understanding Is the Major Determinant for Public Perceptions of Human Gene Editing.
    McCaughey T; Budden DM; Sanfilippo PG; Gooden GEC; Fan L; Fenwick E; Rees G; MacGregor C; Si L; Chen C; Liang HH; Pébay A; Baldwin T; Hewitt AW
    Hum Gene Ther; 2019 Jan; 30(1):36-43. PubMed ID: 29926763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioethical issues in genome editing by CRISPR-Cas9 technology.
    Ayanoğlu FB; Elçin AE; Elçin YM
    Turk J Biol; 2020; 44(2):110-120. PubMed ID: 32256147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey on the perception of germline genome editing among the general public in Japan.
    Uchiyama M; Nagai A; Muto K
    J Hum Genet; 2018 Jun; 63(6):745-748. PubMed ID: 29545588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Genetic Editing of the Human Embryo.
    Astarăstoae V; Ioan BG; Rogozea LM; Hanganu B
    Am J Ther; 2023 Mar-Apr 01; 30(2):e126-e133. PubMed ID: 36762925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Public Attitudes Toward Gene Editing of Germlines: The Impact of Moral and Hereditary Concern in Human and Animal Applications.
    Critchley C; Nicol D; Bruce G; Walshe J; Treleaven T; Tuch B
    Front Genet; 2018; 9():704. PubMed ID: 30687386
    [No Abstract]   [Full Text] [Related]  

  • 10. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wisdom of Germline Editing: An Ethical Analysis of the Use of CRISPR-Cas9 to Edit Human Embryos.
    Gumer JM
    New Bioeth; 2019 Jun; 25(2):137-152. PubMed ID: 31130112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stringent criteria needed for germline genome editing of human IVF embryos.
    Chin AHB; Nguma JB; Ahmad MF
    J Assist Reprod Genet; 2024 May; ():. PubMed ID: 38695986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent loss of heterozygosity in CRISPR-Cas9-edited early human embryos.
    Alanis-Lobato G; Zohren J; McCarthy A; Fogarty NME; Kubikova N; Hardman E; Greco M; Wells D; Turner JMA; Niakan KK
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34050011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genome editing in human embryos: ethical concerns and practical applications].
    Akutsu H
    Rinsho Ketsueki; 2019; 60(9):1033-1045. PubMed ID: 31597825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carry on editing.
    Greenfield A
    Br Med Bull; 2018 Sep; 127(1):23-31. PubMed ID: 30202929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making sense of heritable human genome editing: Scientific and ethical considerations.
    Greenfield A
    Prog Mol Biol Transl Sci; 2021; 182():1-28. PubMed ID: 34175039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Germ Line and Heritable Genome Editing: The Global Policy Landscape.
    Baylis F; Darnovsky M; Hasson K; Krahn TM
    CRISPR J; 2020 Oct; 3(5):365-377. PubMed ID: 33095042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes of clinical geneticists and certified genetic counselors to genome editing and its clinical applications: A nation-wide questionnaire survey in Japan.
    Taguchi I; Yamada T; Akaishi R; Imoto I; Kurosawa K; Nakatani K; Nomura F; Hamanoue H; Hyodo M; Murakami H; Yoshihashi H; Yotsumoto J; Kosugi S
    J Hum Genet; 2019 Sep; 64(9):945-954. PubMed ID: 31273322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes of Members of Genetics Professional Societies Toward Human Gene Editing.
    Armsby AJ; Bombard Y; Garrison NA; Halpern-Felsher BL; Ormond KE
    CRISPR J; 2019 Oct; 2(5):331-339. PubMed ID: 31599688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a CRISPR view of early human development: applications, limitations and ethical concerns of genome editing in human embryos.
    Plaza Reyes A; Lanner F
    Development; 2017 Jan; 144(1):3-7. PubMed ID: 28049687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.